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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S487Methods: Umbilical cords were dissected to obtain WJ and MC was
obtained from aw2 cm section of whole cord, which was minced into
small (w2mm2) pieces and digested in collagenase I for 1 h at 37C.
Resulting cells were cultured in DMEM-F12, 10 % FCS and Penicillin/
streptomycin. Flow cytometry, immunocytochemistry and Western
blotting was used to characterise cell markers indicative of pluripotency
(SOX2, Nanog, REX-1, OCT3/4, SSEA-3, 4, TRA-1-60, TRA-1-81 and
alkaline phosphatase) and immunogenicity (using co-stimulatory
markers, CD40, 80, 86, in addition to HLA-G, Indoleamine 2 3-dioxy-
genase and HLA-DR) before and after stimulationwith IFN-g (500 ng/ml
for 48 h). BMSC and UCMSC were cultured with allogeneic CD4þ T cells
(responder cells) (at a ratio of 1:5) labelled with violet proliferation dye
in addition to peripheral blood mononuclear cells (PBMC) (used as
stimulator cells) for 5 days. Controls were CD4þ Tcells and PBMCs alone.
After 5 days T cells were analysed via ﬂow cytometry to assess their
proliferative response.
Results: All cells showed positivity for the markers SOX2, Nanog, REX-1,
SSEA-4, Alkaline phosphatase, TRA-1-81, HLA-G and were negative for
OCT 3/4, SSEA-3 and the co-stimulatory markers CD40, CD80, CD86.
BMSC were positive for TRA-1-60, whereas UC MSC were negative.
Differences were seen between BMSC and UC MSC after stimulation
with IFN-g. UC MSC remained negative for the co-stimulatory markers
CD40, 80, 86 and HLA-DR after IFN-g stimulation, but, BMSC showed
up-regulation of HLA-DR after exposure to IFN-g. All cells were negative
for IDO before treatment with IFN-g and became positive after stim-
ulation. T cell proliferation was found to be supressed in all cultures
containing either BMSCs or UC MSCs, showing that cells from both of
these sources have immunomodulatory properties and may be capable
of dampening down immune response in vivo.
Conclusions: Umbilical cord derived MSCs may have more promise
than BMSCs as an allogeneic cell therapy as they do not produce co-
stimulatory markers or MHC (major histocompatibility complex) class II
antigens after culture in vitro in an inﬂammatory environment such as
that which may be found in an osteoarthritic joint.
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Purpose:We previously reported that a cocktail of bonemorphogenetic
protein (BMP)-2, insulin and triiodothyronine (BIT) could trigger
redifferentiation of human chondrocytes after their ampliﬁcation on
plastic, with cartilage-characteristic matrix reconstruction when the
chondrocytes were seeded in collagen sponges (Claus et al., 2011).
However, this matrix was not homogenously distributed in the scaf-
folds, most likely because the collagen sponges were cultivated in static
conditions. With the aim of enhancing cellular access to nutrients and
the soluble factors, bi-directional ﬂow was tested to perfuse the scaf-
folds during cartilage reconstruction.
Methods: After 3 weeks of ampliﬁcation on plastic, HAC were seeded
then cultivated for 21 days in collagen sponges under bi-directional
ﬂow, by using a prototype of OPB (Oscillating Perfusion Bioreactor). We
established a program of perfusion including phases of high and low
perfusion speeds to alternate sequences of cell stimulation and matrix
deposition. For comparison, cultures of HAC in collagen sponges were
performed in static conditions. The status of the chondrocyte pheno-
type and the nature of the matrix synthesized in collagen sponges were
evaluated by real time PCR, Western Blotting and immunohistochem-
istry analyses. The viability and cell proliferation were also monitored.
Results: The results clearly indicate that perfusion improves cartilage
matrix deposition within the sponges, in comparison with static con-
ditions. More precisely, in the sponges cultured in the bioreactor,
redifferentiated and metabolically active HAC produced a cartilaginous
matrix rich in type II and type IX collagens and in glycosaminoglycans,
with no sign of hypertrophy. Interestingly, a much lower amount of type
I collagen was produced in the sponges cultivated in dynamic con-
ditions, indicating therefore that bi-directional perfusion limits the risk
of ﬁbrocartilage formation.Conclusions: The combination of HAC, collagen sponges, and the BIT
cocktail with the bi-directional perfusion bioreactor favors the recon-
struction of hyaline cartilage. Importantly, bi-directional perfusion
abolishes the spatial concentration gradients routinely observed in
scaffolds in static culture. This study also demonstrates the value of a
multi-factorial approach for the design of cell-based grafts for cartilage
repair.
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Purpose: Platelet Rich Plasma (PRP), a blood-derived product rich in
growth factors, is a promising treatment for cartilage defects in
Osteoarthritis (OA). Despite its widespread application there is a lack of
in deep studies to demonstrate its real efﬁcacy. Aim of the present study
was to investigate the effects of two different PRP preparations on
chondrocytes from osteoarthritis patients evaluating both the expres-
sion and secretion of pro-inﬂammatory and anabolic markers and the
production of some extracellular matrix proteins.
Methods: Blood from ten human volunteers was used to prepare two
different formulation of PRP: 1) Platelet Rich Plasma with a low con-
centration of platelets and leukocytes (P-PRP), 2) Platelet Rich Plasma
with a high levels of platelets and leukocytes (L-PRP). Before the
experiments, each PRP was evaluated for growth factors and cytokines
content. Chodrocytes were obtained from cartilage tissues of patients
with OA (Kellgren-Lawrence grade I-II-III) undergone surgery and were
isolated by enzymatic procedure. The cells were seeded at a high den-
sity and cultured in presence of three different concentrations (5,10 and
20%) of both P-PRP and L-PRP for 7 days. The in vitro effects of the two
different PRPs on chondrocytes were evaluated through the analysis of
cell proliferation, matrix production and expression of speciﬁc genes.
Results: Our data showed that L-PRP contains higher levels of growth
factors and cytochines compared to P-PRP. Both PRPs at all the concen-
tration evaluated stimulated chondrocyte proliferation throughout the
culture period analyzed; at day 7 P-PRP induced greater cell growth
compared with L-PRP. P-PRP stimulated chondrocyte anabolism as
demonstrated by an increased expression of collagen type II and aggre-
can, while L-PRP promoted catabolic pathways in which different cyto-
kinesare involved.However, L-PRPwasable to induceahigherexpression
of hyaluronic acid synthase-2 and hyaluronan compared to P-PRP.
Conclusions: Our study highlights some effects exerted by two differ-
ent PRP compositions on cultured human chondrocytes. These effects
are reasonably due to the content of platelets, leukocytes, growth fac-
tors and molecules which characterize each compound and that act
synergically to regulate some biological processes. The identiﬁcation of
the optimal amount and ratio of these blood components could ideally
lead to a PRP more suitable for the treatments of cartilage lesions both
of traumatic or degenerative origin.
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Purpose: We are developing the cell therapy, especially using hBMSCs,
for cartilage defect. The result of this therapy would be better if we
could get the cells, having more chondrogenic capacity, enough to tar-
get the cartilage defect. The cell-sheet would be a good candidate of the
applications to get better result. Our colleagues have reported the
